Cmpx stock forecast.

Compass Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. CMPX updated stock price target summary.

Cmpx stock forecast. Things To Know About Cmpx stock forecast.

Oct 2, 2023 · Future criteria checks 0/6. Compass Therapeutics is forecast to grow earnings and revenue by 21.6% and 76.7% per annum respectively while EPS is expected to grow by 25.3% per annum. CMPX: Compass Therapeutics, Inc. - Price and Consensus Chart. Get the latest Price and Consensus Chart for Compass Therapeutics, Inc. from Zacks Investment ResearchNowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.Analyst Forecast. According to 4 analysts, the average rating for CMPX stock is "Strong Buy." The 12-month stock price forecast is $9.33, which is an increase of 452.07% from the latest price.

Stock Screener; ETF Screener; Comparisons; Explore Alpha Picks ... Compass Therapeutics (CMPX) Investor Presentation - Slideshow. Nov. 23, 2022 6:22 AM ET Compass Therapeutics, Inc. (CMPX) SA ...With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.

The average Compass Therapeutics stock price prediction forecasts a potential upside of 528.93% from the current CMPX share price of $1.59. What is CMPX's forecast return on assets (ROA) for 2023-2026?

Stock Price Forecast. The 1 analysts offering 12-month price forecasts for CompX International Inc have a median target of 24.00, with a high estimate of 24.00 and a low estimate of 24.00. The ... CMPX Stock Forecast 2023. Compass Therapeutics boasts a robust drug pipeline, which explains why analysts are bullish on the stock. The Phase 2 and Phase 3 studies for cancer drug CTX-009 extend into H2 2023, at which time the company plans to initiate a Phase 1 study for its CTX-8371 drug also for cancer after filing an Investigational New Drug Application (IND) earlier in 2023.Compass Therapeutics Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction. ... CMPX Related stocks. Symbol 3M %Chg ; CMPX +4.67% : Compass Therapeutics ...Website. 2014. 26. Tom Schuetz. https://www.compasstherapeutics.com. Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company’s product candidates include CTX-009, a bispecific antibody that blocks Delta …Find the latest OPKO Health, Inc. (OPK) stock quote, history, news and other vital information to help you with your stock trading and investing.

Find the latest Compass Therapeutics, Inc. (CMPX) stock forecast, 12-month price target, predictions and analyst recommendations.

Compass Therapeutics Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time CMPX stock price.

Nov 18, 2023 · It follows that stock’s current price would drop -591.82% in reaching the projected high whereas dropping to the targeted low would mean a loss of -403.14% for stock’s current value. Compass Therapeutics Inc (CMPX) estimates and forecasts CMPX stock forecast Our latest prediction for Compass Therapeutics Inc's stock price was made on the March 15, 2023 when the stock price was at 3.56$. In the short term (2weeks), CMPX's stock price should underperform the market by -2.94%. During that period the price should oscillate between -8.72% and +5.46%. 13 may 2022 ... ... stock price fluctuations. StockWatch appears weekly in GEN Edge ... Compass Therapeutics (CMPX). Shares of Compass soared 25% on Thursday ...The consensus price target of analysts on Wall Street is $9.17, which implies an increase of 82.01% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $8.00 and $11.00 respectively. As a result, CMPX is trading at a discount of -566.67% off the target high and -384.85% off the low.NSD:CMPX Detailed Stock Analysis, Stock Price Forecasts, Analyst Ratings, Financial Analysis, Stock News & Historic Quotes

Find the latest Capital Power Corporation (CPXWF) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W ...APRE Stock 12 Months Forecast. $15.00. (300.00% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Aprea Therapeutics in the last 3 months. The average price target is $15.00 with a high forecast of $20.00 and a low forecast of $9.00. The average price target represents a 300.00% change from the last price of $3.75.Step 1: Check Ratings History. In the short term, look to see whether analysts suggest an initiation, upgrade or downgrade for a particular stock. Understand how the rating changed compared to the ...Track Cidara Therapeutics Inc (CDTX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors4 brokers have issued twelve-month target prices for Catalyst Pharmaceuticals' stock. Their CPRX share price targets range from $24.00 to $27.00. On average, they predict the company's stock price to reach $24.75 in the next twelve months. This suggests a possible upside of 67.0% from the stock's current price.Compass Therapeutics, Inc. stock price live 1.66, this page displays NASDAQ CMPX stock exchange data. View the CMPX premarket stock price ahead of the market session or assess the after hours quote.If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.

CMPX stock forecast Our latest prediction for Compass Therapeutics Inc's stock price was made on the March 15, 2023 when the stock price was at 3.56$. In the short term (2weeks), CMPX's stock price should underperform the market by -2.94%. During that period the price should oscillate between -8.72% and +5.46%.Meta Materials, Inc. engages in the manufacture and development of functional materials. Its technology platform enables global brands to deliver products to customers in consumer electronics, 5G ...

The average twelve-month price prediction for Compass Therapeutics is $9.33 with a high price target of $10.30 and a low price target of $8.00. Learn more on CMPX's analyst rating history. Do Wall Street analysts like Compass Therapeutics more than its competitors?$10.50 (510.47% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Compass Therapeutics in the last 3 months. The average price target is $10.50 with a …The stock of Compass Therapeutics Inc (CMPX) has gone down by -4.07% for the week, with a -8.33% drop in the past month and a -29.18% drop in the past quarter. The volatility ratio for the week is 4.13%, and the volatility levels for the past 30 days are 7.49% for CMPX. The simple moving […]Introducing Nasdaq Data Link - The Next Evolution in Data. The right insights, data and technology can create limitless possibilities. Nasdaq Data Link is a powerful, centralized, cloud-based ...Based on short-term price targets offered by seven analysts, the average price target for Compass Therapeutics, Inc. comes to $9.33. The forecasts range from a low of $8.00 to a high of $11.00 ...The Compass Therapeutics, Inc. stock price gained 6.00% on the last trading day (Friday, 17th Nov 2023), rising from $1.50 to $1.59. During the last trading day the stock fluctuated 15.61% from a day low at $1.51 to a day high of $1.74. The price has fallen in 6 of the last 10 days and is down by -14.52% for this period.Compass Therapeutics (CMPX) Stock Forecast & Price Target $1.72 0.00 (0.00%) (As of 01:47 PM ET) Compare Today's Range $1.68 $1.72 50-Day Range $1.40 $2.13 52-Week …

Total Valuation. CMPX has a market cap or net worth of $224.33 million. The enterprise value is $55.37 million. Market Cap. 224.33M. Enterprise Value. 55.37M.

The average Albemarle stock price prediction forecasts a potential upside of 66.63% from the current ALB share price of $121.27. What is ALB's forecast return on equity (ROE) for 2023-2026? (NYSE: ALB) forecast ROE is N/A, which is considered weak.

Complete Compass Therapeutics Inc. stock information by Barron's. View real-time CMPX stock price and news, along with industry-best analysis.As per the forecast and algorithmic analysis, CMPX stock price can be as low as $1.71 which is 1.04% higher than the current price in the next 2 weeks. This prediction may vary from other time period filters for CMPX stock. In many cases to predict stock price, gold and crude oil have been used as extra indicators [36], in some of the works, 43 technical indicators as input features along with LSTM to forecast price ...March 7, 2024. EPS forecast (this quarter) $0.30. Annual revenue (last year) $378.5M. Annual profit (last year) $18.7M. Net profit margin.Most recent stock forecast was given on BGNE, BeiGene, Ltd at 26-Jun-2023 ... CMPX GLUE TNGX TPTX Turning Point Therapeutics NRIX Nurix Therapeutics COGT ...The average twelve-month price prediction for Compass Therapeutics is $9.33 with a high price target of $10.30 and a low price target of $8.00. Learn more on CMPX's analyst rating history. Do Wall Street analysts like Compass Therapeutics more than its competitors?Get the latest CompX International Inc. (CIX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.According to the issued ratings of 6 analysts in the last year, the consensus rating for Mesoblast stock is Hold based on the current 1 sell rating, 3 hold ratings and 2 buy ratings for MESO. The average twelve-month price prediction for Mesoblast is $7.13 with a high price target of $17.00 and a low price target of $1.50.GLTO Stock 12 Months Forecast. $5.67. (808.65% Upside) Based on 4 Wall Street analysts offering 12 month price targets for Galecto in the last 3 months. The average price target is $5.67 with a high forecast of $10.00 and a low forecast of $2.00. The average price target represents a 808.65% change from the last price of $0.62. Jul 11, 2023 · CMPX Stock Forecast 2023. Compass Therapeutics boasts a robust drug pipeline, which explains why analysts are bullish on the stock. The Phase 2 and Phase 3 studies for cancer drug CTX-009 extend into H2 2023, at which time the company plans to initiate a Phase 1 study for its CTX-8371 drug also for cancer after filing an Investigational New Drug Application (IND) earlier in 2023. Total Valuation. CMPX has a market cap or net worth of $224.33 million. The enterprise value is $55.37 million. Market Cap. 224.33M. Enterprise Value. 55.37M.The development of new drugs generally has a high failure rate, and such failures may negatively impact the stock price of the company developing the failed ...

The average TRACON Pharmaceuticals stock prediction of $12.40 implies an upside potential of 392.1% to current levels for this stock.Compass Therapeutics (NASDAQ: CMPX)Compass Therapeutics ...Step 1: Check Ratings History. In the short term, look to see whether analysts suggest an initiation, upgrade or downgrade for a particular stock. Understand how the rating changed compared to the ...Research CompX International's (NYSEAM:CIX) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. Dashboard Markets Discover Watchlist Portfolios Screener. Stocks / Commercial Services; CompX International NYSEAM:CIX Stock Report. Last Price. US$21.81. …Instagram:https://instagram. top 10 stock analysis websitesflipkart usafidelity healthcare etfvestas wind systems stock Feb 3, 2023 · View NASDAQ COMPOSITE COMPX investment & stock information. Get the latest NASDAQ COMPOSITE COMPX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Compass Therapeutics (CMPX) Stock Forecast & Price Target $1.72 0.00 (0.00%) (As of 01:47 PM ET) Compare Today's Range $1.68 $1.72 50-Day Range $1.40 $2.13 52-Week … betwimgn stock forecast This paper proposes and realizes the CNN and LSTM forecasting model with financial news and historical data of stock market, which uses deep learning methods to quantify text and mine the laws ofStock market changes and analyze whether they can predict changes. The changes of stock market and the predictions of the price have become hot topics. When machine learning emerged, it has been used ... when iphone 15 pre order Compass Therapeutics Stock (NASDAQ: CMPX) stock price, news, charts, stock research, profile. ... Dow Drops 100 Points; Verizon Issues Weak Earnings Forecast. Lisa Levin - Jan 24, ...Find the latest VOC Energy Trust (VOC) stock quote, history, news and other vital information to help you with your stock trading and investing.